The final IPO of 2025 is open for Modern Diagnostic & Research Centre. 0.41 crore shares are available at ₹85-90 per share. Allotment will be on January 5th, and listing on BSE SME will be on January 7, 2026.
Modern Diagnostic IPO: The final IPO of 2025 has opened today. This IPO is from Modern Diagnostic & Research Centre, a leading company in the diagnostics sector in India. The company provides a wide range of pathology and radiology services. It has 21 centers across the country, spread over eight states.
The Modern Diagnostic IPO is a book-build issue. The company aims to raise ₹36.89 crore from the market by issuing 0.41 crore fresh shares. There is no offer for sale (OFS) component in this IPO, meaning all shares are being issued by the company. This is the last opportunity for investors this year, as bids can be placed until January 2, 2026.
Modern Diagnostic IPO Price Band and GMP
The IPO price band has been set at ₹85 to ₹90 per share. Investors can bid for shares within this range. According to unlisted market data, as of December 31st morning, Modern Diagnostic shares were trading at a premium of ₹10.
Based on this, the estimated listing price could be ₹100 per share, considering the upper price band of ₹90 for the IPO. This means investors could potentially profit around 11.11% per share. It is important to note that GMP is an unofficial measure and is subject to fluctuations. It does not guarantee any listing gains or losses.
How many shares are available to whom
One lot in the IPO will consist of 1,600 shares. Retail investors must apply for a minimum of two lots, i.e., 3,200 shares. To do so, if investors bid according to the upper price band of the IPO, they will need to invest ₹2.88 lakh.
HNI investors will need to bid for a minimum of three lots, i.e., 4,800 shares. This requires an investment of ₹4.32 lakh. Thus, the investment terms in the IPO are clear, and investors can take a stake according to their capacity.
IPO Management and Listing
Beeline Capital Advisors are the book-running lead managers for this IPO. MUFG Intime India is the issue registrar. Spreadex Securities is the market maker for the company.
The listing date for the IPO is set for January 7, 2026. It will be listed on the BSE SME platform. Investors will await the first trading of the shares on this day, as this is when the actual market value of the share will be determined.
Important Dates for the IPO
Investors should keep track of all important dates related to the IPO. The IPO opened on December 31, 2025, and will be available for investment until January 2, 2026. Share allotment will be on January 5th, and refunds will be issued on January 6th. Shares will also be credited to demat accounts on January 6th. Finally, the shares will be listed on the BSE SME on January 7th.
Keeping these dates in mind is important for investors to bid on time and track their investment according to share allotment and listing.
What does Modern Diagnostic do
Modern Diagnostic & Research Centre is a large diagnostic chain in India. The company provides a variety of pathology and radiology tests. The company provides diagnostic services to both institutional clients and individual patients.
Modern Diagnostic also offers facilities such as home sample collection, online reporting, and customized test packages. It has 21 centers across the country, including 18 labs and 3 diagnostic centers. This distribution network gives the company a b national presence.
Strategy for Investors
Investors investing in this IPO need to understand the price band, GMP, and allotment process. The lot size and minimum investment amount are clear for both retail and HNI category investors.
The estimated listing profit based on GMP is 11 percent, but this should not be taken as a guarantee. Investors should invest according to their portfolio and risk appetite.
Precautions related to investment
Investing in an IPO is attractive, but it also involves risk. Investors should note that the actual listing value will depend on market demand and supply.
